CareFusion Corporation  

(Public, NYSE:CFN)   Watch this stock  
Find more results for Joan B. Gordon
59.17
-0.05 (-0.08%)
After Hours: 59.22 +0.05 (0.08%)
Nov 28, 2:08PM EST  
NYSE real-time data - Disclaimer
Currency in USD
Range 59.12 - 59.34
52 week 37.60 - 59.34
Open 59.18
Vol / Avg. 893,304.00/2.60M
Mkt cap 12.06B
P/E 29.96
Div/yield     -
EPS 1.98
Shares 203.92M
Beta 0.96
Inst. own 94%

Key stats and ratios

Q3 (Sep '14) 2014
Net profit margin 8.24% 10.85%
Operating margin 13.67% 16.16%
EBITD margin - 22.31%
Return on average assets 3.27% 4.58%
Return on average equity 5.69% 7.74%
Employees 16,000 -
CDP Score - -

Address

3750 Torrey View Ct
SAN DIEGO, CA 92130-2622
United States - Map
+1-858-6848880 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

CareFusion Corporation (CareFusion) is a global medical technology company. Its offerings include established brands used in hospitals throughout the United States and approximately 130 countries worldwide. The Company operates in two segments: Medical Systems and Procedural Solutions. The Medical Systems segment is organized around its medical equipment businesses. The Company�s Medical Systems segment�s business units and product lines include Infusion Systems, Dispensing Technologies, and Respiratory Technologies. The Procedural Solutions segment is organized around the Company�s disposable products and reusable surgical instruments businesses. The Company�s Procedural Solutions segment�s business units and product lines include Infection Prevention, Medical Specialties and Specialty Disposables. On October 1, 2013, it completed the acquisition of Grupo Sendal, S.L (Sendal). Effective December 31, 2013, it acquired Vital Signs Inc from GE Healthcare, a unit of General Electric Co.

Officers and directors

Kieran T. Gallahue Chairman of the Board, Chief Executive Officer
Age: 51
Bio & Compensation  - Reuters
James F. Hinrichs Chief Financial Officer
Age: 47
Bio & Compensation  - Reuters
Thomas J. Leonard President - Medical Systems
Age: 46
Bio & Compensation  - Reuters
Joan B. Stafslien Executive Vice President, Chief Compliance Officer, General Counsel, Secretary
Age: 50
Bio & Compensation  - Reuters
Donald Abbey Executive Vice President - Quality, Regulatory and Medical Affairs
Age: 47
Bio & Compensation  - Reuters
Gordon M. La Fortune Executive Vice President - EMEA/APAC Commercial Operations and Global Infusion Disposables
Age: 57
Bio & Compensation  - Reuters
Jonathan Wygant Senior Vice President, Chief Accounting Officer, Controller
Age: 43
Bio & Compensation  - Reuters
Supratim Bose Independent Director
Age: 62
Bio & Compensation  - Reuters
Philip L. Francis Non-Employee Independent Director
Age: 67
Bio & Compensation  - Reuters
Robert F. Friel Non-Employee Independent Director
Age: 58
Bio & Compensation  - Reuters